- 97
- 351 438
Samsung Biologics
South Korea
เข้าร่วมเมื่อ 12 พ.ค. 2014
Welcome to the official Samsung Biologics TH-cam channel.
With proven regulatory approvals, the largest single site capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to provide seamless offerings from development, manufacturing, to laboratory testing services at every stage for biopharmaceutical products while meeting the evolving needs of the global healthcare industry.
By continuously innovating our People, Process, and Portfolio, we will fulfill our mission to become the most trusted partner to our clients working together to achieve "Better Life" for all humanity through biomedicines.
Please subscribe to see what's happening at Samsung Biologics and for all the latest news, visit our website at samsungbiologics.com.
With proven regulatory approvals, the largest single site capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to provide seamless offerings from development, manufacturing, to laboratory testing services at every stage for biopharmaceutical products while meeting the evolving needs of the global healthcare industry.
By continuously innovating our People, Process, and Portfolio, we will fulfill our mission to become the most trusted partner to our clients working together to achieve "Better Life" for all humanity through biomedicines.
Please subscribe to see what's happening at Samsung Biologics and for all the latest news, visit our website at samsungbiologics.com.
Dedicated Antibody-Drug Conjugates (ADC) Facility
Our dedicated, standalone antibody-drug conjugates (ADC) facility is on track for completion within this year. Located across from both Bio Campus I and II, the facility will enable us to offer seamless services from development to manufacturing for your ADC project. Stay tuned for additional updates as we advance to provide innovative therapeutics.
samsungbiologics.com/services/adc
#SamsungBiologics #ADC #biomanufacturing #innovation
samsungbiologics.com/services/adc
#SamsungBiologics #ADC #biomanufacturing #innovation
มุมมอง: 204
วีดีโอ
One-stop mRNA Manufacturing, Samsung Biologics
มุมมอง 20514 ชั่วโมงที่ผ่านมา
At Samsung Biologics, we offer one-stop mRNA manufacturing from start to finish, all at a single site where our experts serve you through a fully-equipped MSAT laboratory, dedicated to mRNA. As a trusted navigator in your novel path to success, we are here to help you forge ahead towards the next breakthrough. To find out more about our offerings, please watch the video.
![[Webinar] Formulation Considerations for the Development of High Concentration Biopharmaceuticals](http://i.ytimg.com/vi/rOcJtk6MAKQ/mqdefault.jpg)
[Webinar] Formulation Considerations for the Development of High Concentration Biopharmaceuticals
มุมมอง 13216 ชั่วโมงที่ผ่านมา
This webinar discusses the challenges of developing high-concentration biopharmaceutical formulations, such as increased aggregation, viscosity, and opalescence. It also presents case studies on how to manage these issues and practical strategies for streamlining the formulation process, with a focus on enabling subcutaneous administration for patient convenience. 👉 Link: samsungbiologics.com/m...
Trusted end-to-end CDMO partner for your journey | OPCU Webinar
มุมมอง 5063 หลายเดือนก่อน
Given the complexities of biologics development, a CDMO partner that has the capacity and expertise to support the entire drug journey is crucial for success. In our recent webinar in collaboration with Outsourced Pharma Capacity Update, Thomas Rohrer, Senior Director of Bioconjugate Technology Support, highlighted our comprehensive service offerings as well as expansion in the ADC space. You c...
Manufacturing concepts for antibody-drug conjugates | Webinar
มุมมอง 1.8K4 หลายเดือนก่อน
The antibody-drug conjugate (ADC) market is witnessing rapid growth due to increased demand for targeted cancer therapies and improved conjugation technologies. Watch our STAT webinar to gain insights on the latest ADC advancements and discover the critical role CDMOs play in ensuring safe and efficient manufacturing processes. Check out the full video: [Link] #SamsungBiologics #ADCs #cdmo
Harnessing Analytical Development To Empower Process Development For Successful Manufacturing
มุมมอง 2844 หลายเดือนก่อน
A well-established analytical development method enables the safe and efficient development of molecules in compliance with regulatory requirements. This webinar, where Steven Lal, lead CDO analytical scientist, will share insights on our capabilities and case studies for our new offerings, Host Cell Protein (HCP) identification and Sequence Variant Analysis (SVA). #SamsungBiologics #Anlaytical...
Expediting Biologics preclinical development timeline through downstream strategies | Webinar
มุมมอง 1.1K6 หลายเดือนก่อน
At Samsung Biologics, we expedite preclinical development timelines by optimizing tech transfer processes and refining raw material management protocols in downstream processing. Watch our recent webinar on downstream strategies and gain insights on how we accelerate your program toward success. #SamsungBiologics #drugdevelopment #downstream #TechTransfer
Navigating challenges during formulation development | Webinar
มุมมอง 7866 หลายเดือนก่อน
Multiple considerations have to be made during the formulation stage to ensure successful development of a drug product with high stability and efficacy. If you haven’t already, watch our on-demand webinar on formulation development strategies and discover how we tackle challenges and tailor solutions for our clients' unique needs. #samsungbiologics #drugdevelopment #partnership #formulation
Reducing candidate risk with a robust developability assessment tool
มุมมอง 6707 หลายเดือนก่อน
Conducting a thorough developability assessment during the late discovery stage is essential for filtering out candidates that may present significant challenges later in development. Watch this webinar to discover how Samsung Biologics’ rapid developability assessment platform, DEVELOPICK™, systematically screens molecules to identify candidates with the best potential for IND and BLA progress...
What is LIFE? | Our Story
มุมมอง 1K10 หลายเดือนก่อน
What does life mean to us? At Samsung Biologics, we make a positive impact on the world, about reaching out to help others, and about turning seemingly impossible into powerful actions that save and improve lives. This is the essence of our journey. Hear from our people. #samsungbiologics #drivenforlife #mission #biopharma #bettertomorrow
On-Demand Webinar | Enhancing quality by employing cell line replacement and process optimization
มุมมอง 1.1K10 หลายเดือนก่อน
In case you missed it, our webinar on improving productivity by employing cell line replacement, is now available on demand. Our CDO experts, Derrick Katayama, Janet Lee, Daniel Buckley, and Sojeong Lee share their insights on how Samsung Biologics' various proprietary platforms can improve quality and optimize processes for our clients’ successful drug development journey. #samsungbiologics #c...
BIO PLAZA | Your one-stop place to achieve your well-being
มุมมอง 1.1K10 หลายเดือนก่อน
BIO PLAZA | Your one-stop place to achieve your well-being
Expanding Samsung Biologics’ business into Late Discovery/Early Development
มุมมอง 63510 หลายเดือนก่อน
Expanding Samsung Biologics’ business into Late Discovery/Early Development
Optimizing N-glycan Profiles and their effector functions using a design of experiments approach
มุมมอง 69011 หลายเดือนก่อน
Optimizing N-glycan Profiles and their effector functions using a design of experiments approach
S-DUAL™: A novel bispecific antibody scaffold with enhanced heterodimer formation and manufactura..
มุมมอง 1Kปีที่แล้ว
S-DUAL™: A novel bispecific antibody scaffold with enhanced heterodimer formation and manufactura..
Driving force of Samsung Biologics’ competitiveness | Leadership Insights (KOR sub)
มุมมอง 1.3Kปีที่แล้ว
Driving force of Samsung Biologics’ competitiveness | Leadership Insights (KOR sub)
[ON DEMAND] Designing an mRNA process development platform: a quality by design approach
มุมมอง 2.3Kปีที่แล้ว
[ON DEMAND] Designing an mRNA process development platform: a quality by design approach
Life Sciences Knowledge Hub | Interview with Senior Vice President Kevin Sharp
มุมมอง 720ปีที่แล้ว
Life Sciences Knowledge Hub | Interview with Senior Vice President Kevin Sharp
Tackling false-positive endotoxin results in downstream process: A practical approach to β-glucans
มุมมอง 1.7Kปีที่แล้ว
Tackling false-positive endotoxin results in downstream process: A practical approach to β-glucans
Life Sciences Knowledge Hub | Interview with Executive Vice President James Choi
มุมมอง 1.9Kปีที่แล้ว
Life Sciences Knowledge Hub | Interview with Executive Vice President James Choi
Business Review | Partnering with CDMOs for a sustainable future
มุมมอง 1.8Kปีที่แล้ว
Business Review | Partnering with CDMOs for a sustainable future
Contract Pharma | New Approaches in Bispecific Antibody Development
มุมมอง 2Kปีที่แล้ว
Contract Pharma | New Approaches in Bispecific Antibody Development
PharmTech | Key Considerations When Selecting a mRNA CDMO Partner
มุมมอง 1.4Kปีที่แล้ว
PharmTech | Key Considerations When Selecting a mRNA CDMO Partner